BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany's Booming Biotech Industry

With their next-generation mRNA vaccines, the German companies BioNTech and CureVac are at the forefront of pharmaceutical innovation. But U.S. President Joe Biden's plan to suspend patent protections is threatening that position.

from DER SPIEGEL - International https://ift.tt/3eIcslP
via IFTTT